Press Releases
Search
-
19 Jul 2012
bioMérieux - First-Half 2012 Business Review
Sales Up 8.7% at constant exchange rates Of which 2.9% through organic growth bioMérieux China becomes the Group's 3rd largest company, with sales up 48%* Solid 22%* growth in sales of the Full Microb...
-
03 May 2012
bioMérieux Completes its VIDAS® Hepatitis Panel with a New Test for the Diagnosis of Hepatitis C
Marcy l’Etoile, France, May 3, 2012 — bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of VIDAS® Anti-HCV for the detection of the hepatitis C virus (HCV). With th...
-
24 Apr 2012
bioMérieux - First-Quarter 2012 Business Review
Sales up 9.3% at constant exchange rates Of which 3.1% organic growth, in line with objectives Strong momentum* in China (up 47%) and India (up 31%) Solid performance* in industrial applications (up 1...
-
12 Apr 2012
bioMérieux’s Myla® Named as Finalist in the 2012 Medical Design Excellence Awards
Myla middleware recognized for groundbreaking innovation in In Vitro Diagnostics...
-
27 Mar 2012
Detection of Schmallenberg virus made possible by bioMérieux: the ADIAGENE PCR kit has been validated by ANSES
Marcy l’Etoile, France – ADIAGENE, a member of the bioMérieux group and specialized in diagnostics for animal health, has obtained ANSES validation for a kit for the detection of Schmallenberg virus, ...
-
13 Mar 2012
bioMérieux - 2011 Financial Results
Solid financial performance: Sales at constant exchange rates: up 6.5% Including organic growth: up 4.1% Operating margin before non-recurring items: 18% Confirmed medium and long-term growth potentia...